MapLight Therapeutics, Inc.
MPLT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $759,806 | $759,806 | $759,806 | $759,806 |
| - Cash | $64,146 | $33,467 | $50,156 | $38,253 |
| + Debt | $6,006 | $6,205 | $6,395 | $6,579 |
| Enterprise Value | $701,666 | $732,544 | $716,045 | $728,132 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$136 | -$166 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$31,362 | -$29,710 | -$22,173 | -$22,583 |
| % Margin | – | – | – | – |
| Net Income | -$29,418 | -$29,846 | -$22,339 | -$21,229 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.71 | -0.72 | -0.54 | -0.51 |
| % Growth | 1.4% | -33.3% | -5.9% | – |
| Operating Cash Flow | -$31,791 | -$33,967 | -$25,550 | -$21,488 |
| Capital Expenditures | -$31 | -$66 | $0 | -$106 |
| Free Cash Flow | -$31,822 | -$34,033 | -$25,550 | -$21,594 |